Delivery Order SPE2DB20D3304-SPE2DB24FW7E5
Award Date
9/1/24
Potential Completion Date
9/3/24
Potential Value
$3.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The order is for the supply of the product "GVOKE HYPOPEN 2PK 0.5MG/0.1 ML 0.1ML" with a ceiling value of $1,023.67 and a completion date of August 13, 2024. This order is not set aside for any specific business type. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through...
This is a $8,338.30 firm fixed-price delivery order issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of GVOKE HYPOPEN 2PK 0.5MG/0.1 ML 0.1ML medical supplies, with a period of performance through May 21, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,406.79, is for the supply of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML, a pharmaceutical product. The contract has an ultimate completion date of September 24, 2024 and was awarded on September 23, 2024. There is no set-aside designation for this contract. AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML, a medical product, with a ceiling value of $2,770.34 and a performance period through August 30, 2023. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp is a for-profit organization...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML, a specialty pharmaceutical product, with a ceiling value of $3,789.56 and a period of performance through January 24, 2025. The contract is a Firm Fixed Price delivery order and does not have a set-aside designation, indicating open...
The Defense Logistics Agency (DLA) awarded a $4,813.46 firm fixed-price delivery order contract to Amerisourcebergen Drug Corporation's Corporate Office Division for the supply of 4566110655 GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML. The contract, which has a completion date of October 16, 2024, is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025 for the DLA Troop Support Medical to procure a comprehensive range of medical commodities to support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GVOKE HYPOPEN 2PK 0.5MG/0.1 ML 0.1ML medical devices. The contract has a ceiling value of $1,779.36 and an ultimate completion date of August 18, 2022. AmerisourceBergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) through June 2025. The contract is not designated as a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML, a pharmaceutical product, with a ceiling value of $16,637.22. The contract is a firm fixed price delivery order with a completion date of June 30, 2022....
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML, a pharmaceutical product, with a ceiling value of $2,158.78 and an ultimate completion date of August 13, 2024. The contract is a Firm Fixed Price (FFP) Delivery Order, with no set-aside designation. Amerisourcebergen is a prominent supplier of pharmaceutical and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,601.25, is for the supply of GVOKE HYPOPEN 2PK 0.5MG/0.1 ML 0.1ML, a medical device. The contract is a firm fixed-price delivery order with a completion date of February 4, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract...